Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
Drug Transporter (DT) Information
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0227 | ||||
| Gene Name | SLC26A1 | ||||
| Protein Name | Sulfate anion transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
|
||||
| Synonyms | CAON; SAT-1; SAT1; SLC26A1; Solute carrier family 26 member 1 | ||||
| DT Family | Sulfate Permease (SULP) Family ; | ||||
| Tissue Specificity | Expressed most abundantly in the kidney andliver, with lower levels in the pancreas, testis, brain, smallintestine, colon, and lung. | ||||
| Function | This transporter mediates sulfate transport with high affinity, oxalate and bicarbonate. | ||||
| Endogenous Substrate(s) | Cl- | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(α) Genetic Polymorphisms of This DT |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Bicarbonate
|
Phase 3 | Drug Info | Metabolic acidosis | 5C73 | [1] |
| References | |||||
| 1 | SLC26A Gene Family Participate in pH Regulation during Enamel Maturation. PLoS One. 2015 Dec 15;10(12):e0144703. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.